Answers are grounded in this paper and cite their sources.
Neuronal ceroid lipofuscinosis, also known as Batten disease, is an umbrella term for a group of 13 genetically distinct lysosomal storage disorders. Neuronal ceroid lipofuscinosis type 1 is caused by mutations in the gene encoding the lysosomal enzyme palmitoyl-protein thioesterase 1. This fatal condition is characterized by progressive neurodegeneration in the brain and retina. Here, we used a CLN1 mouse model to analyze the effect of an intravitreally transplanted PPT1-overexpressing neural stem cell clone on the progression of the retinal pathology. Analysis of the retinas seven months after the cell transplantation revealed a reduction in storage material, attenuation of reactive astrogliosis and microgliosis, correction of the dysregulated expression of several lysosomal proteins, and partial restoration of the disrupted autophagic flux. While the cell-based enzyme replacement therapy did not prevent the progressive loss of photoreceptor cells, it slowed the degeneration of rod and cone bipolar cells and ganglion cells, and mitigated the deterioration of inner retinal function. These findings suggest that a cell-based intravitreal enzyme replacement therapy represents a promising treatment option for retinal dystrophies in neuronal ceroid lipofuscinoses caused by dysfunction of soluble lysosomal enzymes.
No takes yet. Share an insight, caveat, or question.
Bartsch et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: